Sort
64,565 grants matching “drug discovery”
Collaborative Research: ITR/AP Reconstructing Complex Evolutionary Histories
$813,540Bernard M Moret · University Of New Mexico · · FY2001 · CSE
Rapid point-of-care diagnostic reader for Surface enhanced Raman nanotags in a la
$813,509Prasant Potuluri · Centice Corporation · R44 · FY2008 · GM
Alzheimer Disease Genetic Architecture in African Americans
$813,421Lindsay A. Farrer · Boston University Medical Campus · R01 · FY2020 · AG
Collaborative Research: GCR: Engineering, SocioEconomic and Environmental Convergence of Ocean Wave Energy Research for Remote Coastal Communities
$813,386Lei Zuo · Regents Of The University Of Michigan - Ann Arbor · · FY2024 · O/D
Genomic Database for Candida Albicans
$813,322Gavin J Sherlock · Stanford University · R01 · FY2009 · DE
Roles of HIV-1 capsid-binding FG-motif containing cellular cofactors in infection
$813,266Mamuka Kvaratskhelia · University Of Colorado Denver · R01 · FY2022 · AI
Novel Catalytic MetalloDrug Targeting IRES RNA for Treatment of HCV Infection
$813,038Ada S Cowan · Metallopharm, Llc · R44 · FY2012 · AA
Conservation and Sustainable Use of Biodiversity in PNG
$813,034Louis R Barrows · University Of Utah · U01 · FY2013 · TW
Functions and Activities of p53 and Mdm2 in Normal and Cancer Cells
$812,976Carol Prives · Columbia Univ New York Morningside · R35 · FY2024 · CA
Clinical Research Design, Epidemiologv and Biostatistics Core
$812,896William S Weintraub · University Of Delaware · U54 · FY2017 · GM
Clinical Research Design, Epidemiologv and Biostatistics Core
$812,896William S Weintraub · University Of Delaware · U54 · FY2015 · GM
Clinical Research Design, Epidemiologv and Biostatistics Core
$812,896William S Weintraub · University Of Delaware · U54 · FY2016 · GM
Longitudinal models of breast cancer for studying mechanisms of therapy response and resistance
$812,870Bryan E. Welm · University Of Utah · U01 · FY2021 · CA
Administrative Core
$812,777Oscar L. Lopez · University Of Pittsburgh At Pittsburgh · P30 · FY2023 · AG
Genetic Control of Addiction by Host and Microbiome
$812,604George M Weinstock · Jackson Laboratory · U01 · FY2018 · DA
Systemic and gastrointestinal targeted CDPK1 inhibitors for cryptosporidiosis
$812,603Gregory D Cuny · University Of Houston · R01 · FY2025 · AI
Discovery of small molecules inhibiting Toll-like receptor-mediated inflammation
$812,562Hans Haecker · St. Jude Children'S Research Hospital · R01 · FY2018 · AI
A Network Biology Approach to Antibiotic Action and Bacterial Defense Mechanisms
$812,500James J Collins · Boston University (Charles River Campus) · DP1 · FY2007 · OD
A Network Biology Approach to Antibiotic Action and Bacterial Defense Mechanisms
$812,500James J Collins · Boston University (Charles River Campus) · DP1 · FY2009 · OD
A Network Biology Approach to Antibiotic Action and Bacterial Defense Mechanisms
$812,500James J Collins · Boston University (Charles River Campus) · DP1 · FY2008 · OD
A Network Biology Approach to Antibiotic Action and Bacterial Defense Mechanisms
$812,500James J Collins · Boston University (Charles River Campus) · DP1 · FY2010 · OD
Mouse Models to Delineate a Unique Metabolic and Skeletal Network
$812,444Clifford J Rosen · Mainehealth · R01 · FY2009 · AR
Development of Spleen Tyrosine Kinase (SYK) negative allosteric modifiers for therapeutic intervention in Alzheimer's disease.
$812,379Michael Mullan · Archer Pharmaceuticals, Inc. · R42 · FY2020 · AG
Mouse Models of Human Cancer Database
$812,369Carol J Bult · Jackson Laboratory · R01 · FY2023 · CA
Adiponectin Secretion Enhancer Synthetic Organic Drug Discovery and Development
$812,130John H Streiff · Discoverybiomed, Inc. · R44 · FY2015 · DK